Monoclonal and polyclonal antibodies are functionally interchangeable in some assay formats, but antibody class can significantly influence assay performance depending on the application.
Monoclonal antibodies recognize a single, defined epitope. This epitope specificity minimizes cross-reactivity and lot-to-lot variability, making monoclonal antibodies the preferred choice for applications requiring high reproducibility and precise binding characterization — including ELISA, flow cytometry, and epitope mapping studies.
Polyclonal antibodies, by comparison, recognize several distinct epitopes on the same antigen. This polyepitopic binding profile provides an advantage in neutralization assays, where broader antigen coverage improves the ability to block biological activity — an outcome that a monoclonal antibody's single-epitope binding may not achieve as effectively, particularly if the targeted epitope is not functionally critical to antigen activity.
Anti-Interferon Antibodies from PBL Assay Science
PBL Assay Science offers monoclonal and polyclonal antibodies raised against interferons (IFNs) across multiple mammalian species. A key differentiator from other commercially available anti-IFN antibodies is subtype-level characterization: PBL's human IFN-alpha antibodies have been evaluated for reactivity against a comprehensive panel of human IFN-alpha subtypes. Full subtype specificity data is available in the human IFN-alpha antibody comparison chart.